|
|
16Won Ki Kang  This is an abridged 2009 data mining report for Won Ki Kang. The complete report is available only to the community members. As a guest user you can access the free unabridged reports for this author for the years prior to 2007: 2002, 2003, 2004, 2005, 2006.
Authoratory community membership is free for a member of educational or government organization. If you are already a community member please login or create FREE account to start using Authoratory now!
![]() Summary for 2009 [at-glance overview of Won Ki Kang work for the selected year as suggested by data mining algorithms]This is an Authoratory overview of author Won Ki Kang. According to available data, in 2009 Won Ki Kang published at least 16 articles. This work was completed in collaboration with several authors including Park, Young Suk and Lee, Jeeyun. Many other authors have collaborated with Won Ki Kang as well. There is no information about the funding or the grants awarded to support this work.
Won Ki Kang has rank 12 when compared to all other authors using the keyword Taxoids. Analysis of the article abstracts and the titles suggests that Won Ki Kang professional interests are focused around "recurrent metastatic colon", "phase ii study" and "metastatic colon cancer". These might also be referred to as "colon cancer", "phase ii" or "patients advanced". Statistical analysis shows that Won Ki Kang's writing is likely to contains terms "patients", "cancer", "chemotherapy", "metastatic", "clinical" and "survival".
The majority of Won Ki Kang articles are affiliated with Divisions Division of Hematology/Oncology, Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, #50 50 Ilwon-dong Irwon-dong Gangnam-Gu, Kangnam-gu, Seoul, 135-710, South Korea. Luckily, several email addresses are on file. Images [images we found on the Internet for Won Ki Kang]loading...
Do you know Won Ki Kang who matches the profile above? Click the photo and let us know!
Alternative names (1) [other authors with names similar to Won Ki Kang]Year 2009 Charts [Won Ki Kang frequent coauthors and the most common unique vocabulary terms for the selected year]Historical Performance Charts [graphical overview of Won Ki Kang publication and funding history for the range of years]Emails (2) [email addresses extracted from Won Ki Kang affiliations]hidden, requires login Won Ki Kang Coauthors (81) [all coauthors with the number of joint publications]hidden, requires login Affiliations (7) [condensed summary of the Won Ki Kang affiliations, the leading number and the color conveys importance]Key Opinion Leader In [Won Ki Kang is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]- 12Taxoids | 29Organoplatinum Compounds | 55Neoplasm Metastasis | 62Antineoplastic Combined Chemotherapy Protocols | 159Stomach Neoplasms | 328Survival Rate | 343Prognosis | 564Neoplasm Staging
Keywords (32) [keywords assigned to Won Ki Kang articles by PubMed, the leading number and the color conveys importance]Won Ki Kang Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Won Ki Kang might be a good expert witness on these terms]Reader's Comments (0) [comments posted by readers of Won Ki Kang profile]Funding (0) [selected NIH grants to Won Ki Kang and the award amounts for recent years]- award information is not available
Won Ki Kang Articles (16) [selected PubMed articles for the year 2009 with the links to a full text at PubMed]Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy. (2009) >> Divisions of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul, 135-710, South Korea. 3Kim, Seung Tae, 15Chun, Ho-Kyung, 10Kim, Jin Yong, 12Rhee, Poong-Lyul, 15Lee, Woo Yong, 8Kim, Dae Shick, 6Kim, Hee Cheol, 14Park, Young Suk, 2Yun, Haeran, 13Park, Se Hoon, 22Lee, Jeeyun, 11Lim, Ho Yeong, 12Yun, Seong Hyeon, 35Kim, Young Ho, 13Park, Joon Oh, 10Chang, Dong Kyung, 10Cho, Yong Beom, 16Kang, Won Ki.The effect of DNA mismatch repair (MMR) status on oxaliplatin-based first-line chemotherapy as in recurrent or metastatic colon cancer. (2009) >> Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul, 135-710, South Korea. 3Kim, Seung Tae, 15Chun, Ho-Kyung, 10Kim, Jin Yong, 12Rhee, Poong-Lyul, 15Lee, Woo Yong, 8Kim, Dae Shick, 6Kim, Hee Cheol, 14Park, Young Suk, 2Yun, Haeran, 13Park, Se Hoon, 22Lee, Jeeyun, 11Lim, Ho Yeong, 12Yun, Seong Hyeon, 35Kim, Young Ho, 13Park, Joon Oh, 10Chang, Dong Kyung, 10Cho, Yong Beom, 16Kang, Won Ki.Clinical implications of esophagorespiratory fistulae in patients with esophageal squamous cell carcinoma (SCCA). (2009) >> Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul, 135-710, South Korea. 2Kim, Kwanmien, 21Park, Keunchil, 1Shim, Yong-Mok, 5Park, Hee Chul, 13Ahn, Yong Chan, 15Park, Yeon Hee, 6Im, Young-Hyuck, 2Hong, Jung Yong, 16Kang, Won Ki, 3Choi, Moon Ki.A phase I trial of S-1 with oxaliplatin in patients with relapsed and metastatic colorectal cancer. (2009) >> Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, #50 Ilwon-Dong, Gangnam-Gu, Seoul 135-710, South Korea. 3Lee, Yuna, 11Lim, Ho Yeong, 13Park, Joon Oh, 5Kim, Hyeong Su, 1Kang, Eun Mi, 10Park, Min Jae, 14Park, Young Suk, 16Kang, Won Ki, 22Lee, Jeeyun, 13Park, Se Hoon, 1Lee, Hui Young, 9Uhm, Ji Eun.Clinical significance of a serum CA15-3 surge and the usefulness of CA15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer. (2009) >> Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong Gangnam-gu, Seoul, 135-710, Korea. 21Park, Keunchil, 7Kim, Kyoung Ha, 9Chang, Myung Hee, 15Park, Yeon Hee, 6Im, Young-Hyuck, 10Park, Min Jae, 11Kim, Hyo Song, 17Ahn, Jin Seok, 12Jun, Hyun Jung, 16Kang, Won Ki.The efficacy of frontline platinum-based combination chemotherapy in advanced adenocarcinoma of the ampulla of Vater. (2009) >> Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul, South Korea. 3Kim, Seung Tae, 4Choi, Dong Wook, 9Choi, Seong-Ho, 11Lee, Kyu Taek, 14Park, Young Suk, 13Park, Se Hoon, 22Lee, Jeeyun, 11Lim, Ho Yeong, 7Lee, Jong Kyun, 13Park, Joon Oh, 3Heo, Jin-Seok, 16Kang, Won Ki, 1Lee, Kwang Hyuk.Survival benefit from ovarian metastatectomy in colorectal cancer patients with ovarian metastasis: a retrospective analysis. (2009) >> Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-dong Kangnam-gu, Seoul, 135-710, Korea. 15Chun, Ho-Kyung, 15Lee, Woo Yong, 9Kim, Byoung-Gie, 12Bae, Duk-Soo, 14Lee, Su Jin, 6Kim, Hee Cheol, 11Lee, Jeong-Won, 14Park, Young Suk, 22Lee, Jeeyun, 11Lim, Ho Yeong, 12Yun, Seong Hyeon, 6Choi, Chel Hun, 10Cho, Yong Beom, 16Kang, Won Ki, 7Kim, Tae-Joong.Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study. (2009) >> Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Kangnam-Gu, Seoul, Korea. 4Shin, Dong Bok, 2Oh, Do Youn, 14Park, Young Suk, 17Im, Seock-Ah, 1Lee, Namsu, 2Shin, Sang Jun, 11Hong, Yong Sang, 22Lee, Jeeyun, 13Park, Se Hoon, 11Lim, Ho Yeong, 6Byun, Jae Ho, 13Park, Joon Oh, 7Ahn, Joong Bae, 9Jung, Kyung Hae, 16Kim, Tae Won, 16Kang, Won Ki.Expression of activated signal transducer and activator of transcription 3 predicts poor clinical outcome in gastric adenocarcinoma. (2009) >> Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. 9Lim, Do Hoon, 7Sohn, Tae Sung, 1Kong, Jeehyun, 14Park, Young Suk, 13Park, Se Hoon, 22Lee, Jeeyun, 12Kim, Sung, 11Lim, Ho Yeong, 1Kim, Junga, 12Kim, Kyoung-Mee, 8Noh, Jae Hyung, 13Park, Joon Oh, 3Bae, Jae Moon, 12Park, Cheol Keun, 16Kang, Won Ki, 4Choi, Min Gew.A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer. (2009) >> Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-dong Kangnam-gu, Seoul, 135-710, South Korea. 5Lim, Do Hyoung, 9Chang, Myung Hee, 11Kim, Hyo Song, 12Jun, Hyun Jung, 14Park, Young Suk, 9Yi, Seong Yoon, 13Park, Se Hoon, 22Lee, Jeeyun, 1Uhm, Jieun, 11Lim, Ho Yeong, 5Ji, Sang Hoon, 13Park, Joon Oh, 7Kim, Kyoung Ha, 10Park, Min Jae, 16Kang, Won Ki.Kinase mutations and efficacy of imatinib in Korean patients with advanced gastrointestinal stromal tumors. (2009) >> Section of Oncology, Department of Medicine, Asan Medical Center, 388-1 Poongnap-dong, Songpa-ku, Seoul, Korea. 9Lee, Jae-Lyun, 4Shin, Dong Bok, 13Lee, Jung Shin, 1Lee, Heungnam, 4Sym, Sun Jin, 14Park, Young Suk, 9Kang, Yoon-Koo, 17Lee, Kyung Hee, 10Ryu, Min-Hee, 16Kim, Tae Won, 20Bang, Yung-Jue, 10Chang, Heung Moon, 16Kang, Won Ki.A phase II study of oxaliplatin in combination with doxorubicin as first-line systemic chemotherapy in patients with inoperable hepatocellular carcinoma. (2009) >> Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul, 135-710, South Korea. 11Lim, Ho Yeong, 6Koh, Kwang Cheol, 8Paik, Seung Woon, 13Park, Joon Oh, 7Yoo, Byung Chul, 14Park, Young Suk, 16Kang, Won Ki, 22Lee, Jeeyun, 13Park, Se Hoon, 9Uhm, Ji Eun.Treatment outcomes and clinicopathologic characteristics of triple-negative breast cancer patients who received platinum-containing chemotherapy. (2009) >> Department of Medicine, Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. 9Cho, Eun Yoon, 4Choi, Yoon La, 15Park, Yeon Hee, 14Lee, Su Jin, 12Lee, Se-Hoon, 12Jun, Hyun Jung, 9Yi, Seong Yoon, 21Park, Keunchil, 6Im, Young-Hyuck, 10Park, Min Jae, 17Ahn, Jin Seok, 16Kang, Won Ki, 9Uhm, Ji Eun.A prospective, multicenter, phase 2 study of imatinib mesylate in korean patients with metastatic or unresectable gastrointestinal stromal tumor. (2009) >> Department of Internal Medicine, Division of Oncology, Asan Medical Center, Songpa-Gu, Seoul, Korea. 4Shin, Dong Bok, 13Kim, Min Kyoung, 15Kim, Tae-You, 1Lee, Woon Kee, 2Lee, Hyoungnam, 14Park, Young Suk, 9Kang, Yoon-Koo, 4Kang, Jin-Hyoung, 13Park, Joon Oh, 8Roh, Jae Kyung, 17Lee, Kyung Hee, 10Ryu, Min-Hee, 7Kang, Hye Jin, 16Kim, Tae Won, 20Bang, Yung-Jue, 10Chang, Heung Moon, 16Kang, Won Ki, 5Ryoo, Baek-Yeol.Cyclooxygenase-2 is an independent prognostic factor in gastric carcinoma patients receiving adjuvant chemotherapy and is not associated with EBV infection. (2009) >> Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. 12Kim, Sung, 12Kim, Kyoung-Mee, 1Do, In Gu, 8Noh, Jae Hyung, 7Kim, Min-Ji, 1Park, Eun Soo, 7Sohn, Tae Sung, 12Park, Cheol Keun, 16Kang, Won Ki.A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancer. (2009) >> Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, 50 Ilwon-dong, Kangnam-gu, Seoul 135-710, Korea. 5Lim, Do Hyoung, 9Chang, Myung Hee, 11Kim, Hyo Song, 14Park, Young Suk, 12Jun, Hyun Jung, 9Yi, Seong Yoon, 13Park, Se Hoon, 22Lee, Jeeyun, 11Lim, Ho Yeong, 5Ji, Sang Hoon, 13Park, Joon Oh, 7Kim, Kyoung Ha, 10Park, Min Jae, 16Kang, Won Ki, 9Uhm, Ji Eun.
|
|